The U.S, Court of Appeals for the Federal Circuit (CAFC) on Monday, January 6, rejected Laboratory Corporation of America Holdings’ (Labcorp) argument that, among other issues, the Patent Trial and Appeal Board (PTAB) erred in its motivation to combine analysis and ultimate determination that Labcorp had not proven Ravgen, Inc.’s patent claims to be obvious. The opinion was authored by Judge Lourie.

Full Article Available Here